Moderna – Page 13 – Communicable Diseases Research

Decreased and Heterogeneous Neutralizing Antibody Responses Against RBD of SARS-CoV-2 Variants After mRNA Vaccination

mRNA 백신 접종 후 SARS-CoV-2 변이체의 RBD에 대한 감소된 이종 중화 항체 반응

Article

Published on 2022-04-062022-09-11
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, 치료제,

Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies

백신 유도 및 치료 항체에 의한 중화에 대한 SARS-CoV-2 Omicron 변이체의 내성 증가

Article

Published on 2022-04-012022-09-11
Journal: EBioMedicine [Category] COVID19(2023년), SARS, 변종, 진단,

[키워드] antibody Antibody neutralization applied benefit BNT162b2 booster concern decrease disease severity Donor donors effective Effectiveness Efficacy Emergency use highlight immunization Increased incubated lentivirus Lilly luciferase luciferase activity luminometer maintain mapped Moderna monoclonal antibodies monoclonal antibody monoclonal antibody therapies monoclonal antibody therapy mutated neutralization Neutralizing NIH obstacle omicron Omicron variant Pfizer preventing infection PROTECT protein structure pseudotype pseudotyped lentiviruses Regeneron Resistance mutation resistance mutations SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant sera serum Sotrovimab Spike protein T cells target cells the vaccine the vaccines therapeutic Therapies therapy titre Vaccine vaccine efficacy variant was measured
[DOI] 10.1016/j.ebiom.2022.103944 PMC 바로가기 [Article Type] Article

Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England

영국에서 COVID-19 관련 증상, 입원 및 사망에 대한 COVID-19 추가 백신의 효과

Article

Published on 2022-04-012022-09-11
Journal: Nature Medicine [Category] COVID19(2023년), SARS, 변종, 임상,

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination

동종 ChAdOx1-nCoV-19 또는 동종 mRNA-1273 백신과 비교한 이종 ChAdOx1-nCoV-19/mRNA-1273 백신의 면역 반응 및 안전성

Article

Published on 2022-04-012022-09-11
Journal: Journal of the Formosan Medical Association = Taiw [Category] COVID19(2023년), SARS, 변종, 임상,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Adenovirus Adenovirus-vector vaccine Adverse adverse event adverse events AEs Alpha anti-SARS-CoV-2 IgG AstraZeneca B.1.1.7 B.1.617.2 ChAdOx1 ChAdOx1-nCoV-19 comparable coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 vaccines Efficacy enrolled event female four groups group Heterologous heterologous prime-boost homologous homologous or heterologous IgG titers immune response less median age messenger Messenger RNA vaccine Mild Moderna MOST mRNA mRNA-1273 Neutralizing antibody response Neutralizing antibody titer neutralizing antibody titers participant Primary outcome provided recruited RNA SARS-CoV-2 second dose serum Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) significantly higher Support vaccination vaccination schedule Vaccines variant Volunteer was done were recorded
[DOI] 10.1016/j.jfma.2022.02.020 PMC 바로가기 [Article Type] Article

COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram

스크리닝 유방 조영술에서 코로나19 백신 관련 무증상 겨드랑이 림프절병증

Article

Published on 2022-04-012022-09-11
Journal: Academic radiology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술,

Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients

Observational Study

Published on 2022-04-012022-10-04
Journal: Journal of Nephrology [Category] COVID19(2023년), SARS, 임상,

[키워드] administration age appear Barcelona BNT162b2 booster dose Cellular responses clinical Clinical efficacy clinical response COVID-19 death defined diagnosed dialysis died dose Efficacy Haemodialysis highlight Hospital admission hospitalizations humoral ICU admission Infection information invasive kidney transplant kidney transplant recipient Kidney transplantation Male sex mechanical ventilation Moderna mRNA mRNA SARS-CoV-2 vaccination. mRNA vaccine mRNA vaccines mRNA-1273 Non-invasive outcome Patient patients Pfizer-BioNTech Population positive RT-PCR Prospective Study required risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination severe COVID-19 significantly higher Spain vaccination vaccine dose were infected
[DOI] 10.1007/s40620-022-01257-5 PMC 바로가기 [Article Type] Observational Study

Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome

원발성 쇼그렌 증후군 환자에서 코로나19 예방접종의 면역원성과 안전성

Article

Published on 2022-04-012022-09-12
Journal: RMD Open [Category] COVID19(2023년), SARS, 진단,

Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation

동종 조혈 세포 이식 후 환자에서 SARS-CoV-2 백신 접종에 대한 항체 반응

Article

Published on 2022-04-012022-09-11
Journal: Transplantation and cellular therapy [Category] COVID19(2023년), SARS, 치료법,

[키워드] age Allogeneic Allogeneic hematopoietic cell transplantation Analysis antibody antibody levels Antibody Response Antibody titer Antibody titers approved BNT162b2 Cell cell transplantation chronic GVHD Cohort conditioning regimen conducted Critical disease domain Efficacy examined Factor Graft-versus-host disease group GVHD had no healthy control healthy controls healthy volunteers hematopoietic Hematopoietic cell transplantation highest homogenous humoral immune response IgA IgG IgM immune response immune responses Immunocompromised patients Immunosuppression information intensity Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 nucleocapsid protein pandemic Patient physician reactivity receiving Receptor-binding domain recipient recipients regimen response revaccination S1 and S2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 pandemic SARS-CoV-2 vaccination second dose significantly lower single center spike glycoprotein stratified subunit Switzerland the SARS-CoV-2 the vaccine transplantation Treatment underlying disease vaccination Vaccine waned was performed
[DOI] 10.1016/j.jtct.2022.01.019 PMC 바로가기 [Article Type] Article

Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death – United States, March 2021-January 2022

COVID-19 관련 침습적 기계적 환기 및 사망 예방에 대한 mRNA 백신 접종의 효과 - 미국, 2021년 3월-2022년 1월

Article

Published on 2022-03-252022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] 변종,

[키워드] 95% CI Alpha B.1.1.529 B.1.1.7 B.1.617.2 BNT162b2 Case-control cause CDC circulating variant control patient COVID-19 COVID-19 mRNA vaccine COVID-19 mRNA vaccines COVID-19 vaccination death Delta died dose doses effective Effectiveness eligible enrolled evaluated had more Hospitalization hospitalizations Hospitalized illness onset Immunocompromised IMV In-hospital death Invasive mechanical ventilation Mechanical median age medical condition Moderna mRNA mRNA vaccine mRNA vaccines mRNA-1273 Older omicron outcome Pfizer-BioNTech Preventing PROTECT Respiratory failure SARS-CoV-2 treated United States vaccination vaccine dose vaccine doses virus with COVID-19
[DOI] 10.15585/mmwr.mm7112e1 PMC 바로가기 [Article Type] Article

How (not) to mobilize health workers in the fight against vaccine hesitancy: Experimental evidence from Germany’s AstraZeneca controversy

Randomized Controlled Trial

Published on 2022-03-162022-10-05
Journal: BMC Public Health [Category] 임상,